Abstract
Gentamicin and tobramycin have been compared in vitro and as single-drug therapy in patients with a serious infection caused by gram-negative rods. In vitro, a slight advantage of tobramycin over gentamicin has been found against Pseudomonas aeruginosa. Cross-resistance between gentamicin and tobramycin has been observed for gentamicin-resistant strains of P. aeruginosa and Providence but was not always present. The clinical effectiveness of gentamicin and tobramycin was similar: 14 (45.1%) out of the 31 patients in each series responded favorably. The clinical results were much better in urinary tract infections (66% of favorable responses) than in wound infections, pulmonary infections, septicemia, and meningitis (26% of favorable responses). The frequency of adverse reactions encountered in the present series was similar for both drugs.
Full text
PDF![133](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/5201d552a3ba/aac00332-0033.png)
![134](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/91fe9f987fe1/aac00332-0034.png)
![135](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/39705b41a274/aac00332-0035.png)
![136](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/bb5c277f9d75/aac00332-0036.png)
![137](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/b70e15bed5bf/aac00332-0037.png)
![138](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/428934/859b9ab27696/aac00332-0038.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crowe C. C., Sanders E. Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin? Antimicrob Agents Chemother. 1972 Nov;2(5):415–416. doi: 10.1128/aac.2.5.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis W. W., Stout T. R. Disc plate method of microbiological antibiotic assay. II. Novel procedure offering improved accuracy. Appl Microbiol. 1971 Oct;22(4):666–670. doi: 10.1128/am.22.4.666-670.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Cappel R., Daneau D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother. 1972 Dec;2(6):470–475. doi: 10.1128/aac.2.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Daneau D., de Maertelaer V. Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):104–111. doi: 10.1002/cpt1973141104. [DOI] [PubMed] [Google Scholar]
- Klastersky J., Geuning C., Mouawad E., Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest. 1972 Feb;61(2):117–120. doi: 10.1378/chest.61.2.117. [DOI] [PubMed] [Google Scholar]
- Meyer R. D., Young L. S., Armstrong D. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol. 1971 Dec;22(6):1147–1151. doi: 10.1128/am.22.6.1147-1151.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol. 1972 Jan;23(1):4–7. doi: 10.1128/am.23.1.4-7.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]